<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7330273\results\search\disease\results.xml">
  <result pre="prospectively collect epidemiological and virological data on patients hospitalized with" exact="influenza" post="virus infection. Here, we describe influenza virus strain circulation"/>
  <result pre="on patients hospitalized with influenza virus infection. Here, we describe" exact="influenza" post="virus strain circulation in the GIHSN participant countries during"/>
  <result pre="factors associated with complicated hospitalization among patients admitted with laboratory-confirmed" exact="influenza" post="illness. Methods The study enrolled patients who were hospitalized"/>
  <result pre="with acute respiratory symptoms and who had symptoms consistent with" exact="influenza" post="within the 7 days before admission. Enrolled patients were tested"/>
  <result pre="patients were tested by reverse transcription-polymerase chain reaction to confirm" exact="influenza" post="virus infection. &quot;Complicated hospitalization�? was defined as a need"/>
  <result pre="patients. Factors associated with complicated hospitalization in influenza-positive patients included" exact="chronic obstructive pulmonary disease" post="(15–&amp;lt; 50 years and ≥ 65 years), diabetes (15–&amp;lt; 50 years), male sex (50–&amp;lt; 65 years), hospitalization during"/>
  <result pre="(≥65 years). Chronic obstructive pulmonary disease (50–&amp;lt; 65 years), other chronic conditions (15–&amp;lt; 50 years)," exact="influenza" post="A (50–&amp;lt; 65 years), and hospitalization during the last 12 months (&amp;lt; 15 years)"/>
  <result pre="a longer hospital stay. The proportion of patients with complicated" exact="influenza" post="did not differ between influenza A and B. Conclusions"/>
  <result pre="proportion of patients with complicated influenza did not differ between" exact="influenza" post="A and B. Conclusions Complicated hospitalizations occurred in over"/>
  <result pre="Complicated hospitalizations occurred in over 10% of patients hospitalized with" exact="influenza" post="virus infection. Factors commonly associated with complicated or longer"/>
  <result pre="or longer hospitalization differed by age group but commonly included" exact="chronic obstructive pulmonary disease," post="diabetes, and hospitalization during the last 12 months. Keywords Influenza"/>
  <result pre="Influenza Hospitalization Mortality Risk factors Epidemiology Background Each year, seasonal" exact="influenza" post="epidemics cause an estimated 3 to 5 million severe"/>
  <result pre="diseases are considered to have the highest risk of severe" exact="influenza" post="illness [3, 4]. Hospitalization and death due to influenza,"/>
  <result pre="Disease Control and Prevention collect data on hospitalizations with laboratory-confirmed" exact="influenza" post="illness through a network covering approximately 9% of the"/>
  <result pre="detailed data are needed from geographically diverse settings over several" exact="influenza" post="seasons to assess how the different influenza viruses affect"/>
  <result pre="settings over several influenza seasons to assess how the different" exact="influenza" post="viruses affect clinically meaningful outcomes. Recognizing this need, the"/>
  <result pre="sites linked with local health authorities, each of which coordinates" exact="influenza" post="surveillance at participating hospitals according to a common core"/>
  <result pre="to investigate the associations between severe illness, patient characteristics, and" exact="influenza" post="virology. In the 2017–2018 season, the GIHSN included 20"/>
  <result pre="findings from 2012–2013 [5], 2013–2014 [8], 2014–2015 [9], and 2016–2017" exact="influenza" post="seasons [10]. The studies have shown that all strains"/>
  <result pre="seasons [10]. The studies have shown that all strains of" exact="influenza" post="can result in hospitalization, intensive care unit (ICU) admission,"/>
  <result pre="regions or countries. In addition, these studies have confirmed that" exact="influenza" post="can cause serious outcomes not only in older adults,"/>
  <result pre="we report the results from the GIHSN for the 2017–2018" exact="influenza" post="season. In addition to describing the epidemiology of hospitalized"/>
  <result pre="data from patients hospitalized with acute respiratory symptoms during the" exact="influenza" post="season [11]. All sites share the same core protocol"/>
  <result pre="share the same core protocol and use RT-PCR to confirm" exact="influenza" post="virus infection. The core protocol was approved by the"/>
  <result pre="and at least one respiratory symptom (cough, sore throat, or" exact="shortness" post="of breath) consistent with influenza and had to have"/>
  <result pre="symptom (cough, sore throat, or shortness of breath) consistent with" exact="influenza" post="and had to have been hospitalized ≤7 days after the"/>
  <result pre="be hospitalized ≤7 days after the appearance of symptoms associated with" exact="influenza" post="(see Additional file 2 for diagnosis codes). Patients were"/>
  <result pre="local language, are used to collect patient demographics, comorbidities, and" exact="influenza" post="vaccination status through face-to-face interviews of patients or legal"/>
  <result pre="had received at least one dose of a 2017–2018 seasonal" exact="influenza" post="vaccine ≥14 days before the onset of symptoms. Physicians involved"/>
  <result pre="(&amp;lt; 15, 15–&amp;lt; 50, 50–&amp;lt; 65, and ≥65 years). For admissions aged ≥15 years, covariates included" exact="cardiovascular disease," post="chronic obstructive pulmonary disease (COPD), diabetes, obesity, other chronic"/>
  <result pre="50–&amp;lt; 65, and ≥65 years). For admissions aged ≥15 years, covariates included cardiovascular disease," exact="chronic obstructive pulmonary disease" post="(COPD), diabetes, obesity, other chronic conditions, sex, current smoking,"/>
  <result pre="disease (COPD), diabetes, obesity, other chronic conditions, sex, current smoking," exact="influenza" post="type (A vs B), antiviral prescription during the current"/>
  <result pre="episode, hospitalization during the previous 12 months, site (as random effect)," exact="influenza" post="vaccination status, and age. For admissions aged &amp;lt; 15 years, covariates"/>
  <result pre="admissions aged &amp;lt; 15 years, covariates included any chronic condition, sex, age," exact="influenza" post="type (A vs. B), antiviral prescription during the current"/>
  <result pre="episode, hospitalization during the previous 12 months, site (as random effect)," exact="influenza" post="vaccination status, and age. Factors tested in the mixed"/>
  <result pre="of the sites included in the GIHSN during the 2017–2018" exact="influenza" post="season (Paris [France], Ivory Coast, Kazakhstan, Peru, Poland, and"/>
  <result pre="hospitals Included patients Inclusion period (calendar week and year of" exact="influenza" post="season) Influenza transmission zone a St. Petersburg (Russian Federation)"/>
  <result pre="South America All sites 46 12,803 a World Health Organization" exact="influenza" post="transmission zone [14] Fig. 1 Disposition and influenza positivity"/>
  <result pre="Health Organization influenza transmission zone [14] Fig. 1 Disposition and" exact="influenza" post="positivity of included patients. Community-dwelling patients residing in predefined"/>
  <result pre="hospitals and hospitalized &amp;lt; 48 h with presenting complaints potentially associated with" exact="influenza" post="were eligible. Patients aged &amp;gt; 5 years had to have ≥1"/>
  <result pre="headache, or myalgia) and ≥ 1 respiratory symptom (cough, sore throat, or" exact="shortness" post="of breath) and had to have been hospitalized &amp;lt; 7 days"/>
  <result pre="patients with comorbidities or underlying diseases, the most common was" exact="cardiovascular disease" post="(23.8% [3048/12,803]). Twenty percent of adult patients (1300/6516) were"/>
  <result pre="29.2% had been hospitalized in the previous 12 months. The overall" exact="influenza" post="vaccination rate was 14.3%, and antivirals were used by"/>
  <result pre="Of the 12,803 included patients, 4306 (33.6%) tested positive for" exact="influenza" post="virus infection by RT-PCR (Fig. 1). In the influenza"/>
  <result pre="for influenza virus infection by RT-PCR (Fig. 1). In the" exact="influenza" post="transmission zones of North America (Canada), Eastern Europe (Moscow,"/>
  <result pre="Asia (China), and South West Europe (Spain, Serbia, and France)," exact="influenza" post="was first detected during the last few weeks of"/>
  <result pre="South West Europe. In Eastern Asia, all strains co-circulated, but" exact="influenza" post="A/H1N1pdm09 virus was dominant. Even within these transmission zones,"/>
  <result pre="zones, however, strain circulation varied substantially (Fig. 3). For example," exact="influenza" post="B/Yamagata-like virus was common at all sites within the"/>
  <result pre="at all sites within the East Europe transmission zone, but" exact="influenza" post="A/H3N2 virus was common only at the St. Petersburg"/>
  <result pre="file 7). Likewise, within the South West Europe transmission zone," exact="influenza" post="B/Yamagata-like virus was common at all sites, but influenza"/>
  <result pre="zone, influenza B/Yamagata-like virus was common at all sites, but" exact="influenza" post="A/H3N2 virus was common only in Spain (Fig. 3"/>
  <result pre="2 Influenza strain circulation by year-week and World Health Organization" exact="influenza" post="transmission zone. Influenza strains were detected by RT-PCR. An"/>
  <result pre="could have been positive for more than one strain of" exact="influenza" post="Fig. 3 Influenza strain circulation by site and overall"/>
  <result pre="could have been positive for more than one strain of" exact="influenza" post="In the Central American Caribbean transmission zone (Mexico), the"/>
  <result pre="Central American Caribbean transmission zone (Mexico), the timing of seasonal" exact="influenza" post="was similar to that of the Northern Hemisphere transmission"/>
  <result pre="the Northern Hemisphere transmission zones. However, strain circulation differed, with" exact="influenza" post="A/H3N2 (67.2%) virus dominating and little influenza B detected."/>
  <result pre="circulation differed, with influenza A/H3N2 (67.2%) virus dominating and little" exact="influenza" post="B detected. In the Temperate South America transmission zone"/>
  <result pre="B detected. In the Temperate South America transmission zone (Argentina)," exact="influenza" post="circulated earlier (weeks 30 to 39 of 2017), with"/>
  <result pre="influenza circulated earlier (weeks 30 to 39 of 2017), with" exact="influenza" post="B/Yamagata-like (49.0%) and A/H1N1pdm09 (45.1%) viruses dominating. In contrast"/>
  <result pre="(49.0%) and A/H1N1pdm09 (45.1%) viruses dominating. In contrast to the" exact="influenza" post="transmission zones in the Northern Hemisphere, two distinct peaks"/>
  <result pre="transmission zones in the Northern Hemisphere, two distinct peaks of" exact="influenza" post="activity were detected in Southern Africa (South Africa) and"/>
  <result pre="Asia (India). In Southern Africa, a first peak, dominated by" exact="influenza" post="A/H1N1pdm09 virus, occurred between weeks 18 and 28 of"/>
  <result pre="18 and 28 of 2017, and a second, dominated by" exact="influenza" post="A/H3N2 virus, between weeks 30 and 42 of 2017."/>
  <result pre="of 2017. In Southern Asia, a first peak, dominated by" exact="influenza" post="A/H1N1pdm09 virus, occurred between week 41 of 2017 and"/>
  <result pre="and week 1 of 2018 and a second, dominated by" exact="influenza" post="A/H3N2 virus, between weeks 3 and 9 of 2018."/>
  <result pre="weeks 3 and 9 of 2018. No discernable peak of" exact="influenza" post="circulation was detected in Eastern Africa (Kenya), although influenza"/>
  <result pre="of influenza circulation was detected in Eastern Africa (Kenya), although" exact="influenza" post="A/H1N1pdm09 virus dominated. Overall, across all regions of the"/>
  <result pre="A/H1N1pdm09 virus dominated. Overall, across all regions of the GIHSN," exact="influenza" post="B/Yamagata-like virus (26.1% of influenza-positive patients) and influenza A/H3N2"/>
  <result pre="the GIHSN, influenza B/Yamagata-like virus (26.1% of influenza-positive patients) and" exact="influenza" post="A/H3N2 (25.6%) were the most frequently detected strains, closely"/>
  <result pre="B/Victoria-like virus was detected in 2.3% of influenza-positive patients, unsubtyped" exact="influenza" post="A virus in 12.2%, and influenza B of unknown"/>
  <result pre="of influenza-positive patients, unsubtyped influenza A virus in 12.2%, and" exact="influenza" post="B of unknown lineage in 12.7%. Except in Mexico"/>
  <result pre="unknown lineage in 12.7%. Except in Mexico and South Africa," exact="influenza" post="B/Yamagata-like was the dominant B lineage detected in all"/>
  <result pre="CI, 1.10–2.60]) (Fig. 5). Prescription of antivirals during the current" exact="influenza" post="episode was associated with complicated hospitalization in influenza-positive admissions"/>
  <result pre="&amp;lt; 15 years. The frequency of complicated hospitalization did not differ between" exact="influenza" post="A and B for any age group. The frequency"/>
  <result pre="mixed effects logistic regression adjusted for age and vaccination for" exact="influenza" post="during the previous 12 months and with site as a"/>
  <result pre="defined as ICU admission, mechanical ventilation, or death. Abbreviations: COPD," exact="chronic obstructive pulmonary disease;" post="CVD, cardiovascular disease Length of hospital stay The mean"/>
  <result pre="ventilation, or death. Abbreviations: COPD, chronic obstructive pulmonary disease; CVD," exact="cardiovascular disease" post="Length of hospital stay The mean length of hospital"/>
  <result pre="CI, 0.59–4.94]) were associated with a longer hospital stay and" exact="influenza" post="B (vs. A) with a shorter hospital stay (coefficient,"/>
  <result pre="aged ≥65 years. Length of hospital stay did not differ between" exact="influenza" post="A and B for any age group. The length"/>
  <result pre="by one unit (i.e. from yes to no). Abbreviations: COPD," exact="chronic obstructive pulmonary disease;" post="CVD, cardiovascular disease Discussion The current study showed that"/>
  <result pre="yes to no). Abbreviations: COPD, chronic obstructive pulmonary disease; CVD," exact="cardiovascular disease" post="Discussion The current study showed that during the 2017–2018"/>
  <result pre="disease Discussion The current study showed that during the 2017–2018" exact="influenza" post="season, approximately 10% of all hospitalized cases of influenza"/>
  <result pre="2017–2018 influenza season, approximately 10% of all hospitalized cases of" exact="influenza" post="virus infection were complicated, as defined by admission to"/>
  <result pre="or death. Factors associated with complicated hospitalization in patients with" exact="influenza" post="virus infection included COPD, diabetes, and hospitalization during the"/>
  <result pre="diabetes, and hospitalization during the previous 12 months, although male sex," exact="cardiovascular disease," post="and some lifestyle factors (smoking and obesity) were also"/>
  <result pre="complicated hospitalization and a longer hospital stay in patients with" exact="influenza" post="virus infection. Most of these are known risk factors"/>
  <result pre="infection. Most of these are known risk factors for severe" exact="influenza" post="illness [4]. In addition to these factors, prescription of"/>
  <result pre="frequency of complications, probably because antivirals were mostly prescribed for" exact="influenza" post="cases with a high likelihood of developing complications. Influenza"/>
  <result pre="are often thought to result in more severe illness than" exact="influenza" post="B infections [15]. The current study, however, did not"/>
  <result pre="The current study, however, did not find a difference between" exact="influenza" post="A and B or between A/H1N1pdm09 and A/H3N2 in"/>
  <result pre="hospitalization. It also did not find a consistent difference between" exact="influenza" post="A and B in the risk for individual components"/>
  <result pre="of complicated hospitalization or in the length of hospital stay:" exact="influenza" post="B was associated with shorter hospital stay in influenza-positive"/>
  <result pre="systematic literature review concluding that clinical presentation and severity of" exact="influenza" post="illness do not appear to differ between influenza strains"/>
  <result pre="severity of influenza illness do not appear to differ between" exact="influenza" post="strains [16]. During the 2017–2018 influenza season, influenza accounted"/>
  <result pre="appear to differ between influenza strains [16]. During the 2017–2018" exact="influenza" post="season, influenza accounted for approximately one-third of hospital admissions"/>
  <result pre="differ between influenza strains [16]. During the 2017–2018 influenza season," exact="influenza" post="accounted for approximately one-third of hospital admissions with influenza-like"/>
  <result pre="of hospital admissions with influenza-like symptoms, which agrees with previous" exact="influenza" post="seasons in the GISHN, where proportions were between 21"/>
  <result pre="31% [8–10, 17]. As in previous studies, all strains of" exact="influenza" post="were detected, with widely varying strain circulation between sites"/>
  <result pre="even neighboring regions. Influenza B/Yamagata was the most frequently detected" exact="influenza" post="strain, although A/H3N2 and A/H1N1pdm09 were nearly as common."/>
  <result pre="in the 2017–2018 Northern Hemisphere and 2018 Southern Hemisphere trivalent" exact="influenza" post="vaccines, Yamagata was the dominant lineage of influenza B"/>
  <result pre="Hemisphere trivalent influenza vaccines, Yamagata was the dominant lineage of" exact="influenza" post="B [18, 19]. Finally, as in previous studies, more"/>
  <result pre="previous studies, more than half of the patients hospitalized with" exact="influenza" post="virus infection did not have known chronic conditions, highlighting"/>
  <result pre="virus infection did not have known chronic conditions, highlighting that" exact="influenza" post="can cause severe illness even in individuals without high-risk"/>
  <result pre="extensive global virological data and clinical data on severe seasonal" exact="influenza" post="illness. Data from the GIHSN can be used to"/>
  <result pre="from the GIHSN can be used to identify associations between" exact="influenza" post="virology/epidemiology, patient characteristics, and severe cases of influenza illness."/>
  <result pre="associations between influenza virology/epidemiology, patient characteristics, and severe cases of" exact="influenza" post="illness. In the current study, we pooled data from"/>
  <result pre="and a common core protocol for identifying hospitalized cases of" exact="influenza" post="illness. In addition, to reduce bias caused by false-negative"/>
  <result pre="of the effects. We did not examine the effect of" exact="influenza" post="vaccination on complications or length of hospital stay because"/>
  <result pre="of hospital stay because of low vaccination rates; the overall" exact="influenza" post="vaccination rate across all sites and all included patients"/>
  <result pre="for more than half of the sites, the rate of" exact="influenza" post="vaccination was below 10%, although a few sites had"/>
  <result pre="patients. Given the limitations of influenza-like-illness case definitions for predicting" exact="influenza" post="in individuals, particularly in older adults, to identify the"/>
  <result pre="in older adults, to identify the maximum number of hospitalized" exact="influenza" post="cases, potential cases were identified based on the presence"/>
  <result pre="the presence of any acute respiratory symptoms possibly associated with" exact="influenza" post="rather than based on a specific influenza-like illness case"/>
  <result pre="specificity of the inclusion criteria, specificity was ensured by confirming" exact="influenza" post="virus infection by RT-PCR. Care should be taken when"/>
  <result pre="showed that more than one in ten hospitalized cases of" exact="influenza" post="virus infections detected during the 2017–2018 influenza season was"/>
  <result pre="hospitalized cases of influenza virus infections detected during the 2017–2018" exact="influenza" post="season was complicated by need for mechanical ventilation, admission"/>
  <result pre="death. Common factors associated with an increased risk of severe" exact="influenza" post="were also found to be associated with complicated or"/>
  <result pre="these patients, but the study did not find differences between" exact="influenza" post="strains. The study also provides further evidence that influenza"/>
  <result pre="between influenza strains. The study also provides further evidence that" exact="influenza" post="can cause severe illness even in individuals without high-risk"/>
  <result pre="and appropriate use of antivirals influence complicated hospitalization due to" exact="influenza" post="virus infection. Supplementary information LINK Additional file 1: Supplemental"/>
  <result pre="1: Supplemental Table 1. Admission diagnoses possibly associated with an" exact="influenza" post="infection in patients ≥5 years of age. LINK Additional file"/>
  <result pre="2: Supplemental Table 2. Admission diagnoses possibly associated with an" exact="influenza" post="infection in patients &amp;lt; 5 years of age. LINK Additional file"/>
  <result pre="circulation by year-week for individual sites within the East Europe" exact="influenza" post="transmission zone. LINK Additional file 8: Supplemental Figure 2."/>
  <result pre="by year-week for individual sites within the South West Europe" exact="influenza" post="transmission zone. LINK Additional file 9: Supplemental Figure 3."/>
  <result pre="CI Confidence interval COPD Chronic obstructive pulmonary disease GIHSN Global" exact="influenza" post="hospital surveillance network ICU Intensive care unit OR Odds"/>
  <result pre="de France created by Sanofi Pasteur in 2015 to support" exact="influenza" post="epidemiological research. In addition, the Foundation for Influenza Epidemiology"/>
  <result pre="respiratory mortality: a modelling studyLancet20183911285130010.1016/S0140-6736(17)33293-229248255 3.collab: World Health OrganizationVaccines against" exact="influenza" post="WHO position paper - November 2012Wkly Epidemiol Rec20128746147623210147 4.ColemanBLFadelSAFitzpatrickTThomasSMRisk"/>
  <result pre="2012Wkly Epidemiol Rec20128746147623210147 4.ColemanBLFadelSAFitzpatrickTThomasSMRisk factors for serious outcomes associated with" exact="influenza" post="illness in high- versus low- and middle-income countries: systematic"/>
  <result pre="meta-analysisInfluenza Other Respir Viruses201812222910.1111/irv.1250429197154 5.Puig-BarberaJTormosASomininaABurtsevaELaunayOCiblakMAet al.First-year results of the global" exact="influenza" post="hospital surveillance network: 2012-2013 northern hemisphere influenza seasonBMC Public"/>
  <result pre="of the global influenza hospital surveillance network: 2012-2013 northern hemisphere" exact="influenza" post="seasonBMC Public Health20141456410.1186/1471-2458-14-56424903737 6.BlantonLDuganVGAbd ElalAIAlabiNBarnesJBrammerLet al.Update: influenza activity -"/>
  <result pre="2012-2013 northern hemisphere influenza seasonBMC Public Health20141456410.1186/1471-2458-14-56424903737 6.BlantonLDuganVGAbd ElalAIAlabiNBarnesJBrammerLet al.Update:" exact="influenza" post="activity - United States, September 30, 2018-February 2, 2019MMWR"/>
  <result pre="10 Apr 2019. (2019). 8.Puig-BarberaJNatividad-SanchoATrushakovaSSomininaAPisarevaMCiblakMAet al.Epidemiology of hospital admissions with" exact="influenza" post="during the 2013/2014 northern hemisphere influenza season: results from"/>
  <result pre="of hospital admissions with influenza during the 2013/2014 northern hemisphere" exact="influenza" post="season: results from the global influenza hospital surveillance networkPLoS"/>
  <result pre="the 2013/2014 northern hemisphere influenza season: results from the global" exact="influenza" post="hospital surveillance networkPLoS One201611e015497010.1371/journal.pone.015497027196667 9.Puig-BarberaJBurtsevaEYuHCowlingBJBadurSKynclJet al.Influenza epidemiology and influenza"/>
  <result pre="global influenza hospital surveillance networkPLoS One201611e015497010.1371/journal.pone.015497027196667 9.Puig-BarberaJBurtsevaEYuHCowlingBJBadurSKynclJet al.Influenza epidemiology and" exact="influenza" post="vaccine effectiveness during the 2014–2015 season: annual report from"/>
  <result pre="effectiveness during the 2014–2015 season: annual report from the global" exact="influenza" post="hospital surveillance networkBMC Public Health201616Suppl 175710.1186/s12889-016-3378-127556802 10.Baselga-MorenoVTrushakovaSMcNeilSSomininaANunesMCDraganescuAet al.Influenza epidemiology"/>
  <result pre="hospital surveillance networkBMC Public Health201616Suppl 175710.1186/s12889-016-3378-127556802 10.Baselga-MorenoVTrushakovaSMcNeilSSomininaANunesMCDraganescuAet al.Influenza epidemiology and" exact="influenza" post="vaccine effectiveness during the 2016-2017 season in the global"/>
  <result pre="influenza vaccine effectiveness during the 2016-2017 season in the global" exact="influenza" post="hospital surveillance network (GIHSN)BMC Public Health20191948710.1186/s12889-019-6713-531046725 11.GIHSN: Global Influenza"/>
  <result pre="(2011). 15.SuSChavesSSPerezAD'MelloTKirleyPDYousey-HindesKet al.Comparing clinical characteristics between hospitalized adults with laboratory-confirmed" exact="influenza" post="a and B virus infectionClin Infect Dis20145925225510.1093/cid/ciu26924748521 16.CainiSKronemanMWiegersTEl Guerche-SeblainCPagetJClinical"/>
  <result pre="virus infectionClin Infect Dis20145925225510.1093/cid/ciu26924748521 16.CainiSKronemanMWiegersTEl Guerche-SeblainCPagetJClinical characteristics and severity of" exact="influenza" post="infections by virus type, subtype, and lineage: a systematic"/>
  <result pre="a systematic literature reviewInfluenza Other Respir Viruses20181278079210.1111/irv.1257529858537 17.Puig-BarberaJNatividad-SanchoALaunayOBurtsevaECiblakMATormosAet al.2012-2013 seasonal" exact="influenza" post="vaccine effectiveness against influenza hospitalizations: results from the global"/>
  <result pre="Other Respir Viruses20181278079210.1111/irv.1257529858537 17.Puig-BarberaJNatividad-SanchoALaunayOBurtsevaECiblakMATormosAet al.2012-2013 seasonal influenza vaccine effectiveness against" exact="influenza" post="hospitalizations: results from the global influenza hospital surveillance networkPLoS"/>
  <result pre="influenza vaccine effectiveness against influenza hospitalizations: results from the global" exact="influenza" post="hospital surveillance networkPLoS One20149e10049710.1371/journal.pone.010049724945510 18.World Health Organization: Recommended composition"/>
  <result pre="hospital surveillance networkPLoS One20149e10049710.1371/journal.pone.010049724945510 18.World Health Organization: Recommended composition of" exact="influenza" post="virus vaccines for use in the 2017–2018 northern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2017–2018 northern hemisphere" exact="influenza" post="season. https://www.who.int/influenza/vaccines/virus/recommendations/2017_18_north/en/ . Accessed 03 Sep 2019 (2017). 19.World"/>
  <result pre="03 Sep 2019 (2017). 19.World Health Organization: Recommended composition of" exact="influenza" post="virus vaccines for use in the 2018 southern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2018 southern hemisphere" exact="influenza" post="season. https://www.who.int/influenza/vaccines/virus/recommendations/2018_south/en/. Accessed 03 Sep 2019 (2017). 20.JaegerTFCategorical data"/>
  <result pre="associated with severe outcomes in adult hospitalized patients according to" exact="influenza" post="type and subtypePLoS One201914e021035310.1371/journal.pone.021035330633778 23.NicholsMKAndrewMKHatchetteTFAmbroseABoivinGBowieWet al.Influenza vaccine effectiveness to"/>
  <result pre="serious outcomes in Canadian adults over the 2011/12 through 2013/14" exact="influenza" post="seasons: a pooled analysis from the Canadian immunization research"/>
 </snippets>
</snippetsTree>
